# Detection of Borrelia Bacteria in Early Stage Lyme Borreliosis Using the T2Lyme Panel

> **NCT03581279** · NA · TERMINATED · sponsor: **T2 Biosystems** · enrollment: 18 (actual)

## Conditions studied

- Lyme Disease

## Interventions

- **DEVICE:** T2Lyme Panel testing

## Key facts

- **NCT ID:** NCT03581279
- **Lead sponsor:** T2 Biosystems
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-05-08
- **Primary completion:** 2019-10-31
- **Final completion:** 2019-10-31
- **Target enrollment:** 18 (ACTUAL)
- **Why stopped:** Enrollment levels insufficient to continue.
- **Last updated:** 2022-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03581279

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03581279, "Detection of Borrelia Bacteria in Early Stage Lyme Borreliosis Using the T2Lyme Panel". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03581279. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*